VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer. 2004 Aug 01; 101(3):578-86.
View in:
PubMed
subject areas
Administration, Oral
Bile Duct Neoplasms
Bile Ducts, Intrahepatic
Capecitabine
Carcinoma, Hepatocellular
Cholangiocarcinoma
Cohort Studies
Deoxycytidine
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Fluorouracil
Follow-Up Studies
Gallbladder Neoplasms
Humans
Liver Neoplasms
Male
Multivariate Analysis
Probability
Proportional Hazards Models
Retrospective Studies
Survival Analysis
Treatment Outcome
authors with profiles
LEE M ELLIS
ROBERT A WOLFF
JEAN NICOLAS VAUTHEY
MANAL M HASSAN
STEVEN CURLEY